MassChallenge Startups Create Impact


Startups Accelerated


Funding Raised


Revenue Generated


Jobs Created

Our startups

Be inspired. Search our startups.

Therapeutic Vision, Inc.

Therapeutic Vision has developed Kinostat for treating vision loss in diabetic dogs. In an FDA trial, Kinostat treated dogs were 85% and 84% less likely to develop cataracts and dry eye, respectively vs placebo. Compassionate use shows it safely preserved vision for 8 years. We have provisional approval to market Kinostat pending CMC submission and a bridging study. This drug class also beneficially reduces dry eye and promotes corneal healing in diabetic humans, safely allowing LASIK surgery.
Therapeutic Vision’s Kinostat brings a new paradigm to the clinical treatment of vision loss in diabetic dogs by directly blocking cataract

Connect with Therapeutic Vision, Inc.

Therapeutic Vision, Inc.


2021 Finalist BOS-96

Sub industry

Therapeutics (Pharma / Biotech)


Our mission is to equip bold entrepreneurs to disrupt the status quo and to create meaningful change.